European Archives - Page 481 of 1166 - European Medical Journal

EMJ 7.4 Feature Image

Adult-Onset Idiopathic Cervical Dystonia

Adult-onset idiopathic focal dystonia is the most common type of primary dystonia, and adult-onset idiopathic cervical dystonia (AOICD) is its most prevalent phenotype.

EMJ 7.4 Feature Image

Infographic: MIUC Treatment Landscape

Infographic: MIUC Treatment Landscape. The publication of this infographic was funded by Bristol Myers Squibb

Amputation Alternatives In Diabetic Foot?

This clinical treatment modality was applied to 62 diabetic ulcers on lower extremities for which surgeons had been advised amputation.

EMJ 7.4 Feature Image

EGFR-Mutant Non-small Cell Lung Cancer: Future Perspectives

This review focuses on the state-of-the-art EGFR-TKIs in the treatment of metastatic NSCLC…

Examining pharma's role in protecting the planet

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Channelling the Myotonia Diagnosis: ICNMD Symposium Presentations

Watch full presentations given by Prof. Dr Kristl Claeys, Dr Guillaume Bassez and Prof. John Vissing at the Lupin-sponsored symposium at the 17th International Congress on Neuromuscular Diseases, in July 2022, in Brussels, Belgium.

Overcoming COVID-19 Misinformation: Lessons Learned at the Epicentre of the Outbreak in the USA

THE COVID-19 pandemic has highlighted the dire need to foster increased public confidence in mitigation and prevention strategies through more and better health literacy.

Revealing the true value of medical affairs

Why is the purpose and value of medical affairs sometimes poorly understood by the wider pharma organisation, and what can be done?

Meet GOLD's new catalyst – GSK's John Wahba

Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GS

Davidek Herron on the future of pharma

In his second column, Davidek Herron, Global Head of Digital, Roche, considers this year’s successes and challenges and looks ahead to 2023.